Enovis (ENOV) Expected to Announce Earnings on Wednesday

Enovis (NYSE:ENOV) is expected to be issuing its quarterly earnings data before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.92 per share and revenue of $555.14 million for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

Enovis Stock Performance

Enovis stock opened at $43.55 on Tuesday. The company’s 50-day moving average price is $45.03 and its 200-day moving average price is $44.38. Enovis has a twelve month low of $38.27 and a twelve month high of $63.96. The company has a quick ratio of 1.12, a current ratio of 2.27 and a debt-to-equity ratio of 0.40. The company has a market cap of $2.48 billion, a PE ratio of -19.88 and a beta of 1.94.

Wall Street Analysts Forecast Growth

Separately, Needham & Company LLC restated a “buy” rating and issued a $65.00 target price on shares of Enovis in a report on Thursday, November 7th.

Enovis Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.